MUCOADHESIVE BUCCAL DRUG DELIVERY SYSTEM: REVIEW ARTICLE

Authors

  • Monali Sonawane Department of Pharmaceutics, R. G. Sapkal College of Pharmacy, Anjaneri, Nashik 422213, Maharashtra, India
  • Dattatrey Shinkar Department of Quality Assurance, R. G. Sapkal College of Pharmacy, Anjaneri, Nashik 422213, Maharashtra, India
  • Ravindrasaudagar . 3Department of Pharmaceutical Chemistry, R. G. Sapkal College of Pharmacy, Anjaneri, Nashik 422213, Maharashtra, India

DOI:

https://doi.org/10.22159/ijcpr.2017v9i4.20960

Keywords:

Buccal drug delivey system, Anatomy and Physiology, Bioadhesion, Transmucosal dosage forms, Evaluation parameters

Abstract

The advantage of buccal drug delivery system over the conventional and systemic formulation majority. It helps enhance the bioavailability through bypassing the first-pass metabolism effect. The mucosal surface better absorption and prolong resident time. Bioadhesion can be defined as the phenomenon of interfacial molecular attractive force in midst of the surface of the biological substrate and the natural or synthetic polymers, which allows the polymers to adher to the biological surface for an extended period of time. Among the various transmucosal sites available, mucosa of the buccal cavity was found to be the most convenient and easily approachable site for the delivery of the therapeutic agent for both local and systemic delivery. This review also covers available marketed product as buccal drug delivery system and future aspects of buccal drug delivery system.

Downloads

Download data is not yet available.

References

Bhatt DA, Pethe AM. Mucoadhesive drug delivery systems: an overview. J Pharm Res 2010;3:1743-47.

Soyani AP, Chien YW. Systemic delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Syst 1996;13:85-184.

HH Alur, TP Johnston, AK Mitra. Encyclopedia of pharmaceutical technology. In: J Superbrick, JC Boylan. Eds. Peptides and proteins: buccal absorption. Vol. 20. Marcel Dekker Inc, New York; 2001. p. 193–218.

Patel Mitul, Karigar Asif, Savaliya Pratik. Buccal drug delivery system. Int Res J Pharm 2011;2:4-11.

Khairnar GA, Sayyad FJ. Development of buccal drug delivery system based on mucoadhesive polymers. Int J Pharma Tech Res 2010;2:719-35.

Senel S, Kremer M, Nagy K, Squier C. Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharma Biotechnol 2001;2:175-86.

Aungst BJ, Rogers NJ. Shefter Buccal, sublingual and E. comparison of nasal, rectal, intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther 1988;244:23-7.

Lee WE. Permeation enhancers for the nasal delivery of protein and peptide Ther Biopharm 1990;3:22-5.

Soyani AP, Chien YW. Systemic delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Systems 1996;13:85-184.

Hooda R, Tripathi M, Kapoor K. A review an oral mucosal drug delivery system. Phrma Innovation 2012;1:14-21.

Siddaqui MDN, Garg G, Sharma PK. A short review on A novel approach in oral fast dissolving drug delivery system and their patentsâ€. Adv Biol Res 2011;5:291-303.

Shidhaye SS. Mucoadhesive bilayered patches for administration of sumatriptan. AAPS Pharm Sci Tech 2008;9:909-16.

K Wolff, HJ Honigsmann. Langerhans cells in cell culture ultrastructural studies with thorotrast as a marker. J Ultrastruct Res 1971;36:176–90.

Allen. In: JG Forte. Ed. Handbook of physiology the gastrointestinal physiology-the gastrointestinal physiology, salivary, gastric and hepatobiliary secretions. Vol. III. American Physiological Society, Bethesda, MD; 1989. p. 359–82.

FS Rosen, BJ Bailey. Anatomy and physiology of salivary glands, Grand Rounds presentation, UTMB, Department of Otolaryngology; 2001.

RB Gandhi, JR Robinson. Bioadhesion in drug delivery. Indian J Pharm Sci 1988;50:145-52.

SE Harding, JM Creeth, AJ Rowe. In: A Chester, D Heinegard, A Lundblad, S Svenssion. Eds. Proceedings of the 7th International Glycoconjugates Conference Olsson Reklambyra, Sweden; 1983. p. 558–9.

LMC Collins, C Dawes. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res 1987;66:1300–2.

MJ Levine, PC Jones, RE Looms, MS Reddy, I Al-Hashimi, EJ Bergey. In: IC Mackenzie, CA Squierv, Dablesteen. Eds. Oral mucosal diseases: biology, etiology and therapy, laege-foreningens folag, Copenhagen; 1987. p. 7–9.

L Schenkels, TL Gururaja, MJ Levine. In: MJ Rathbone. Ed. Oral Mucosal Drug Delivery, Marcel Dekker, New York; 1996. p. 191–220.

TC Kontis, ME Johns. Anatomy and physiology of salivary glands. In: Byron J Bailey. Ed. Head and Neck Surgery–Otolaryngology. 2nd edition. Lippincott_raven publishers, Philadelphia, PA; 1998. p. 531–9.

Zhang J. An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers apparent evidence of effective enhancement without tissue damage. Int J Pharm 1994;101:15–22.

Amir H Shojaei, Richard K Chang, Xiaodi Guo, Beth A Burnside, Richard A Couch. Systemic drug delivery via the buccal mucosal route. Pharm Technol 2001;51:70-81.

Thimmasetty J, Pandey GS, Sathesh Babu PR. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches. Pak J Pharm Sci 2008;21:241-8.

Panigrahi L, Snigdha Pattnaik, Ghosal SK. Design and characterization of mucoadhesive buccal patches of diclofenac sodium. Indian J Pharm Sci 2005;67:319-26.

Edsman K. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005;57:3-19.

Steward A. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferon. Int J Pharm 1994;104:145–9.

Aungst BJ, Rogers NJ, Site dependence of absorption-promoting actions of laureth, na salicylate, Na2EDTA, Aprotin Doijad R, et al. Buccoadhesive drug delivery system of isosorbide dinitrate, formulation and evaluation. Indian J Pharm Sci 2006;68:744–8.

Edsman K. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005;57:3-19.

Pillai S. Design and evaluation of buccal films of Isoxsuprine hydrochloride. Res J Pharm Biol Chem Sci 2010;1:158-64.

Alanazi FK. Formulation and physicochemical characterization of buccoadhesive films containing ketorolac. J Drug Delivery Sci Technol 2007;17:1-10.

Hirlekar RS, Kadam VJ. Design of buccal drug delivery system for poorly soluble drug. Asian J Pharm Clin Res 2009;2:49-53.

Gavin P Andrews, Thoma P-Laverty, David S Jones. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biol Pharm 2009;71:505-18.

Published

14-07-2017

How to Cite

Sonawane, M., D. Shinkar, and R. . “MUCOADHESIVE BUCCAL DRUG DELIVERY SYSTEM: REVIEW ARTICLE”. International Journal of Current Pharmaceutical Research, vol. 9, no. 4, July 2017, pp. 1-4, doi:10.22159/ijcpr.2017v9i4.20960.

Issue

Section

Review Article(s)